SGTX is currently covered by 4 analysts with an average potential upside of $4.75 (120.05%) backed by displayed 0 price targets and 10 ratings.
Analysts average stock forecasts to be materialized ratio is 43.75% with an average time for these price targets to be met of 397.75 days.
Highest price target for SGTX is 7, Lowest price target is 3, average price target is 5. For detailed individual stock analysts price targets on SGTX go to the chart section.
Most recent stock forecast was given by MATTHEW HARRISON from MORGAN STANLEY on 26-May-2023. First documented stock forecast 16-Jul-2021.
Currently, out of the existing stock ratings of SGTX - 4 which are a Hold (40%), 6 which are a Buy (60%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Hold
7
$2.5 (55.56%)
2
15 days ago
1/4 (25%)
$0.32 (16.45%)
538
Buy
7
1 years 5 months 13 days ago
1/2 (50%)
$6.12 (176.24%)
516
Buy
7
$2.5 (55.56%)
1 years 6 months 8 days ago
1/1 (100%)
$3.9 (125.81%)
537
Buy
14
$9.5 (211.11%)
1 years 7 months 9 days ago
0/1 (0%)
$8.65 (161.68%)
What is SGTX(Sigilon Therapeutics Inc) average time for price targets to be met?
Which analyst has the current highest performing score on SGTX(Sigilon Therapeutics Inc) with a proven track record?
Which analyst has the current lower performing score on SGTX(Sigilon Therapeutics Inc) with a proven track record?
